Pharmaceuticals, Biotechnology and Life Sciences
Vault CTMS unifies end-to-end clinical information and processes for greater visibility throughout the trial lifecycle BARCELONA, Spain–(BUSINESS WIRE)–More companies are…
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces participation at…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement…
BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members…
At both standard and low budesonide doses, the triple-combination therapy showed a statistically-significant reduction in the rate of moderate or…
LONDON–(BUSINESS WIRE)–OKYO Pharma Limited (LSE: OKYO) August 28, 2019, a biotechnology company focusing on the G Protein Coupled Receptors (GPCR)…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global overactive bladder therapeutics market size is poised to reach USD 300.28 million by 2023, according to a…
—Commercial Performance Data from the European Registry on more than 3,000 Eversense® Commercial Users Found Low Related Adverse Events over…
Median progression-free survival and overall response rate doubled among patients receiving EPd compared to pomalidomide and low-dose dexamethasone alone Second…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…